MCKESSON CORP
For the period ended Mar 31, 2026. Filed May 8, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed May 8, 2026
MCK$1,082.59+2.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. Business
INDEX TO BUSINESS
| Section | Page |
|---|---|
| General | 3 |
| Business Segments | 4 |
| North American Pharmaceutical | 4 |
| Oncology & Multispecialty | 7 |
| Prescription Technology Solutions | 8 |
| Medical-Surgical Solutions | 8 |
| Investments, Restructuring, Business Combinations, and Divestitures | 8 |
| Competition | 8 |
| Patents, Trademarks, Copyrights, and Licenses | 9 |
| Human Capital | 9 |
| Government Regulation | 10 |
| Other Information about the Business | 13 |
| Forward-Looking Statements | 14 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.